CTRI/2021/01/030340尚未招募3 期
A Comparitive Study Between Mirabegron And Tamsulosin For Ureteric Stent Related Morbidity
Atif Abdullah C0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients undergoing uretero-renoscopic lithotripsy with double J stent placement as treatment for ureteric calculus
排除标准
- •Patients with bilatral stone disease, urosepsis, pregnancy, uncontrolled hypertension and residual stones
研究者
相似试验
已完成
2 期
Comparison of Mirabegron, Tamsulosin and Solifenacin for relieving stent related symptoms.CTRI/2019/02/017808Post Graduate Institute of Medical Education and Research150
尚未招募
不适用
Comparison of mirabegron versus tamsulosin patients of benign prostate enlargement with overactive bladdder symptoms.CTRI/2018/12/016541niversity College of Medical Sciences
尚未招募
3 期
A study to find out which is the better drug between tamsulosin and mirabegron in treating patients having ureteric stents for stent related urinary complaintsCTRI/2019/11/022115Dr Josef B Pachikara
尚未招募
4 期
Comparing the efficacy of Mirabegron in reducing urinary symptoms associated with cerebrovascular accidentsCTRI/2023/03/050511DEPARTMENT OF UROLOGY KASTURBA MEDICAL COLLEGE MANIPA
尚未招募
4 期
Comparing the efficacy of Mirabegron in reducing urinary symptoms associated with Parkinsons diseaseCTRI/2023/01/048770DEPARTMENT OF UROLOGY KASTURBA MEDICAL COLLEGE MANIPA